MYOVANT SCIENCES LTD., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of Debt SecuritiesIndenture • November 13th, 2017 • Myovant Sciences Ltd. • Pharmaceutical preparations • New York
INDENTURE, dated as of ________, among MYOVANT SCIENCES LTD., a Bermuda Exempted Limited Company (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
MYOVANT SCIENCES LTD. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFDebt Securities Warrant Agreement • November 13th, 2017 • Myovant Sciences Ltd. • Pharmaceutical preparations • New York
DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between MYOVANT SCIENCES LTD., a Bermuda Exempted Limited Company (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
MYOVANT SCIENCES LTD. and , AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OFCommon Share Warrant Agreement • November 13th, 2017 • Myovant Sciences Ltd. • Pharmaceutical preparations • New York
COMMON SHARE WARRANT AGREEMENT (this “Agreement”), dated as of between MYOVANT SCIENCES LTD., a Bermuda Exempted Limited Company (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
MYOVANT SCIENCES LTD. and , AS WARRANT AGENT FORM OF PREFERENCE SHARE WARRANT AGREEMENT DATED AS OFPreference Share Warrant Agreement • November 13th, 2017 • Myovant Sciences Ltd. • Pharmaceutical preparations • New York
PREFERENCE SHARE WARRANT AGREEMENT (this “Agreement”), dated as of between MYOVANT SCIENCES LTD., a Bermuda Exempted Limited Company (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
